創新醫療(002173.SZ):收到浙江證監局下發的談話通知書
格隆匯 11 月 17日丨 創新醫療(002173.SZ)公佈,公司於2020年11月17日收到浙江證監局下發的《談話通知書》(浙證監公司字[2020]118號),現將《談話通知書》的內容公告如下:
“創新醫療管理股份有限公司:
2020年11月10日,你公司披露《關於召開2020年第一次臨時股東大會的通知》的公告。為了解相關情況,我局決定對你公司全體蓮事、監事和高級管理人員進行監管談話,請通知相關人員準時參加。請於收到本通知書當日予以公告。
時間:2020年11月18日上午9點
地點:杭州市文三路90號一號樓4樓會議室”
公司董事會對《談話通知書》高度重視,並已將上述內容告知各相關人員,要求其在規定的時間內到浙江證監局接受監管談話。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.